Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
0.585
+0.003 (0.45%)
At close: Oct 21, 2024, 4:00 PM
0.610
+0.025 (4.33%)
After-hours: Oct 21, 2024, 6:05 PM EDT
Outset Medical Revenue
Outset Medical had revenue of $27.39M in the quarter ending June 30, 2024, a decrease of -24.01%. This brings the company's revenue in the last twelve months to $116.43M, down -9.94% year-over-year. In the year 2023, Outset Medical had annual revenue of $130.38M with 13.00% growth.
Revenue (ttm)
$116.43M
Revenue Growth
-9.94%
P/S Ratio
0.25
Revenue / Employee
$242,552
Employees
480
Market Cap
30.45M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 130.38M | 15.00M | 13.00% |
Dec 31, 2022 | 115.38M | 12.77M | 12.45% |
Dec 31, 2021 | 102.60M | 52.67M | 105.47% |
Dec 31, 2020 | 49.94M | 34.86M | 231.18% |
Dec 31, 2019 | 15.08M | 13.07M | 651.27% |
Dec 31, 2018 | Pro | Pro | Pro |
Sep 30, 2013 | Pro | Pro | Pro |
Sep 30, 2012 | Pro | Pro | Pro |
Sep 30, 2010 | Pro | Pro | Pro |
Sep 30, 2009 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 72.07M |
Burning Rock Biotech | 70.15M |
ImmuCell | 23.22M |
DarioHealth | 19.15M |
Marker Therapeutics | 3.73M |
Longeveron | 1.23M |
IGC Pharma | 1.06M |
OM News
- 16 hours ago - The Schall Law Firm Encourages Investors To Join A Securities Fraud Case Against Outset Medical, Inc. - Accesswire
- 1 day ago - Outset Medical Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 2 days ago - The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Outset Medical, Inc. - Accesswire
- 3 days ago - Outset Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 4 days ago - Outset Medical (OM) Faces Delisting Threat Amidst Regulatory Woes and Investor Lawsuit - Hagens Berman - Accesswire
- 4 days ago - Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - OM - PRNewsWire
- 5 days ago - Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman - GlobeNewsWire
- 5 days ago - Investors in Outset Medical, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – OM - GlobeNewsWire